Literature DB >> 19199534

Incidence of and preoperative risk factors for Staphylococcus aureus bacteremia and chest wound infection after cardiac surgery.

Zeina A Kanafani1, Jean Marie Arduino, Lawrence H Muhlbaier, Keith S Kaye, Keith B Allen, Yehuda Carmeli, G Ralph Corey, Sara E Cosgrove, Thomas G Fraser, Anthony D Harris, Adolf W Karchmer, Ebbing Lautenbach, Mark E Rupp, Eric D Peterson, Walter L Straus, Vance G Fowler.   

Abstract

OBJECTIVE: Staphylococcus aureus infections after cardiac surgery result in significant morbidity and mortality. Identifying patients at elevated risk for these infections preoperatively could facilitate efforts to reduce infection rates. The objectives of this study were to estimate the incidence of postoperative S. aureus infections in cardiac surgery patients, to identify preoperative risk factors for these infections, and to establish a patient risk profile by means of data available to clinicians prior to surgery.
DESIGN: Cohort study.
SETTING: Eight medical centers that participate in the Society of Thoracic Surgeons National Cardiac Database. PATIENTS: Patients who were undergoing elective cardiac surgery during the period January 1, 2000 through December 31, 2004.
METHODS: Clinical and microbiological data from 16,386 patients were combined. Multivariable stepwise logistic regression analysis was performed to predict S. aureus infection, which was defined by culture results.
RESULTS: Of the 16,386 patients, 205 (1.3%) developed S. aureus bloodstream or chest wound infection within 90 days after surgery. On multivariable analysis, bootstrap-validated preoperative risk factors for S. aureus bloodstream or chest wound infection included a body mass index greater than 40 (adjusted odds ratio [aOR], 1.9 [95% confidence interval {CI}, 1.1-3.2]), chronic renal failure (aOR, 1.8 [95% CI, 1.1-2.9]), and chronic lung disease (aOR, 1.4 [95% CI, 1.0-2.0]). Only 8 patients had all 3 risk factors.
CONCLUSIONS: Although preoperative risk factors can be easily identified, the majority of patients who developed S. aureus infections after cardiac surgery did not have any risk factors. Preventive measures should not be restricted to a select group of cardiac surgery patients and should rather address the entire patient population.

Entities:  

Mesh:

Year:  2009        PMID: 19199534     DOI: 10.1086/596015

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN: 0899-823X            Impact factor:   3.254


  12 in total

1.  Smoking is a risk factor of organ/space surgical site infection in orthopaedic surgery with implant materials.

Authors:  François Durand; Philippe Berthelot; Celine Cazorla; Frederic Farizon; Frederic Lucht
Journal:  Int Orthop       Date:  2013-02-27       Impact factor: 3.075

2.  Epidemiology and outcome of major postoperative infections following cardiac surgery: risk factors and impact of pathogen type.

Authors:  Luke F Chen; Jean Marie Arduino; Shubin Sheng; Lawrence H Muhlbaier; Zeina A Kanafani; Anthony D Harris; Thomas G Fraser; Keith Allen; G Ralph Corey; Vance G Fowler
Journal:  Am J Infect Control       Date:  2012-05-19       Impact factor: 2.918

3.  Deep sternal wound infection after cardiac surgery: Evidences and controversies.

Authors:  Paolo Cotogni; Cristina Barbero; Mauro Rinaldi
Journal:  World J Crit Care Med       Date:  2015-11-04

4.  Staphylococcus aureus Infections After Elective Cardiothoracic Surgery: Observations From an International Randomized Placebo-Controlled Trial of an Investigational S aureus Vaccine.

Authors:  Keith B Allen; Vance G Fowler; James S Gammie; Jonathan S Hartzel; Matthew T Onorato; Mark J DiNubile; Ajoke Sobanjo-Ter Meulen
Journal:  Open Forum Infect Dis       Date:  2014-08-26       Impact factor: 3.835

5.  Variability of anti-staphylococcal antibodies in healthy volunteers and pre-cardiac surgery patients.

Authors:  Sarka Moravcova; Bonnie Kyle; Hilary Shanahan; Savvas Giannaris; Andrew Smith; Colin Hamilton-Davies
Journal:  Perioper Med (Lond)       Date:  2016-05-27

6.  Innate Immunity of Adipose Tissue in Rodent Models of Local and Systemic Staphylococcus aureus Infection.

Authors:  Andreas Schmid; Thomas Karrasch; Miriam Thomalla; Jutta Schlegel; Bernd Salzberger; Andreas Schäffler; Frank Hanses
Journal:  Mediators Inflamm       Date:  2017-03-27       Impact factor: 4.711

7.  Violation of prophylactic vancomycin administration timing is a potential risk factor for rate of surgical site infections in cardiac surgery patients: a prospective cohort study.

Authors:  Paolo Cotogni; Cristina Barbero; Roberto Passera; Lucina Fossati; Giorgio Olivero; Mauro Rinaldi
Journal:  BMC Cardiovasc Disord       Date:  2017-03-08       Impact factor: 2.298

8.  Risk prediction for Staphylococcus aureus surgical site infection following cardiothoracic surgery; A secondary analysis of the V710-P003 trial.

Authors:  Fleur P Paling; Karina Olsen; Kristin Ohneberg; Martin Wolkewitz; Vance G Fowler; Mark J DiNubile; Hasan S Jafri; Frangiscos Sifakis; Marc J M Bonten; Stephan J Harbarth; Jan A J W Kluytmans
Journal:  PLoS One       Date:  2018-03-21       Impact factor: 3.240

9.  Staphylococcus aureus and repeat bacteremia in febrile patients as early signs of sternal wound infection after cardiac surgery.

Authors:  Teruya Nakamura; Takashi Daimon; Norio Mouri; Hirotada Masuda; Yoshiki Sawa
Journal:  J Cardiothorac Surg       Date:  2014-05-08       Impact factor: 1.637

10.  One Dose of Staphylococcus aureus 4C-Staph Vaccine Formulated with a Novel TLR7-Dependent Adjuvant Rapidly Protects Mice through Antibodies, Effector CD4+ T Cells, and IL-17A.

Authors:  Francesca Mancini; Elisabetta Monaci; Giuseppe Lofano; Antonina Torre; Marta Bacconi; Simona Tavarini; Chiara Sammicheli; Letizia Arcidiacono; Bruno Galletti; Donatello Laera; Michele Pallaoro; Giovanna Tuscano; Maria Rita Fontana; Giuliano Bensi; Guido Grandi; Silvia Rossi-Paccani; Sandra Nuti; Rino Rappuoli; Ennio De Gregorio; Fabio Bagnoli; Elisabetta Soldaini; Sylvie Bertholet
Journal:  PLoS One       Date:  2016-01-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.